IGC Pharma
24 hedge funds and large institutions have $2.19M invested in IGC Pharma in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
90% more capital invested
Capital invested by funds: $1.15M → $2.19M (+$1.04M)
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
14% more funds holding
Funds holding: 21 → 24 (+3)
10% more call options, than puts
Call options by funds: $198K | Put options by funds: $180K
0.21% more ownership
Funds ownership: 4.89% → 5.1% (+0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$146K |
| 2 |
Renaissance Technologies
New York
|
+$112K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$66.1K |
| 4 |
PIA
Powell Investment Advisors
Miami,
Florida
|
+$25.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$66K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29.9K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$26K |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$12.2K |
| 5 |
DP
Dearborn Partners
Chicago,
Illinois
|
-$5.95K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| – | -$4.22K | -4,149 | Closed |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$37 | +36 | +14% |
|
28
Bank of America
Charlotte,
North Carolina
| – | +$229 | +225 | New |
|
29
Fidelity Investments
Boston,
Massachusetts
| – | +$238 | +234 | New |
|
IGC Hedge Fund Activity: Q3 2020 in Review
24 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q3 2020, worth a combined $2.19M — up 90% from $1.15M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IGC positions and 5 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $146K. The largest seller was Virtu Financial, exiting entirely with an estimated $66K sold.
- 24 institutional investors held IGC Pharma (IGC) as of Q3 2020, up from 21 in Q2 2020.
- Funds reported $2.19M of IGC Pharma stock for Q3 2020, up 90% quarter-over-quarter.
- 8 funds opened new IGC Pharma positions in Q3 2020 and 5 closed out, a net change of +3 holders.
- The largest IGC Pharma buyer in Q3 2020 was Susquehanna International Group, an estimated $146K added.
- The largest IGC Pharma seller in Q3 2020 was Virtu Financial, an estimated $66K sold.
Based on aggregated 13F filings for Q3 2020.